PSA density in the diagnosis of prostate cancer in the Chinese population: results from the Chinese Prostate Cancer Consortium.

Author: Zi-Jian SONG ¹ ; Jin-Ke QIAN ² ; Yue YANG ¹ ; Han-Xiao WU ¹ ; Mao-Yu WANG ¹ ; Si-Yuan JIANG ¹ ; Fu-Bo WANG ¹ ; Wei ZHANG ¹ ; Rui CHEN ¹
Author Information

1. Department of Urology, Shanghai Changhai Hospital, The Second Military Medical University, Shanghai 200433, China.
2. Department of Urology, Binhai People's Hospital, Yancheng 224500, China.
Collective Name:Chinese Prostate Cancer Consortium
Publication Type:Research Support, Non-U.S. Gov't
Keywords: Chinese; early detection of cancer; prostate cancer; prostate-specific antigen; prostate-specific antigen density
From: Asian Journal of Andrology 2021;23(3):300-305
CountryChina
Language:English
Abstract: We performed this study to investigate the diagnostic performance of prostate-specific antigen density (PSAD) in a multicenter cohort of the Chinese Prostate Cancer Consortium. Outpatients with prostate-specific antigen (PSA) levels ≥4.0 ng ml